Yanping Gong

Yanping Gong is an Assistant Professor in the Department of Pathology and Molecular Medicine at Queen's University, affiliated with the School of Medicine within the Faculty of Health Sciences. She holds cross-appointments in the same department and is a member of The American Board of Pathology and The Royal College of Physicians and Surgeons. Her research focuses on clinical medicine, clinical sciences, pathology, and health sciences, with a strong emphasis on SARS-CoV-2 serology, antibody responses, and epidemiological studies in healthcare workers and vulnerable populations. Dr. Gong's work also includes developing diagnostic tools and advancing clinical laboratory standards.

Education: She earned her MD (Doctor of Medicine) from Hebei Medical College. Her professional affiliations include Queen’s Laboratory for Molecular Pathology (QLMP), where she contributes to cutting-edge molecular diagnostic research. She is actively involved in consensus guidelines for SARS-CoV-2 serology testing and pediatric laboratory standards through initiatives like the CALIPER project.

Research Trends: Her recent articles emphasize quantitative analysis of antibody responses to SARS-CoV-2 variants (e.g., Omicron), comparative evaluations of serological assays, and understanding immune dynamics in cancer patients and long-term care residents. She has pioneered bioluminescent biosensors for studying viral-receptor interactions and contributed to national pediatric critical value protocols.

Grants & Advising: While specific grants are not detailed here, her cross-appointments and high-impact publications suggest active grant funding. She has no listed advisees at present.

Labs/Teams: She collaborates with the Queen’s Laboratory for Molecular Pathology (QLMP) and interdisciplinary teams in virology, immunology, and clinical diagnostics.